Citation Impact
Citing Papers
Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation
2008
Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.
2006
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Brain mitochondrial iron accumulates in Huntington's disease, mediates mitochondrial dysfunction, and can be removed pharmacologically
2018
Ferroptosis: past, present and future
2020 Standout
Microbiota in health and diseases
2022 Standout
Beta-thalassemia
2010
The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis
2009 Standout
Effects of temperature, time, and solvent ratio on the extraction of phenolic compounds and the anti-radical activity of Clinacanthus nutans Lindau leaves by response surface methodology
2017 Standout
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
Targeting lipid peroxidation and mitochondrial imbalance in Friedreich's ataxia
2015
Nutritional immunity: transition metals at the pathogen–host interface
2012 Standout
Oxidative stress and neurodegeneration: the involvement of iron
2018
Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants
2000
Hematologically Important Mutations: Glucose-6-phosphate Dehydrogenase
2002
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Iron Overload Cardiomyopathy
2010
Hematologically Important Mutations: Glucose-6-phosphate Dehydrogenase
1996
Guidelines for the use and interpretation of adsorption isotherm models: A review
2020 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
2018
Bioavailability enhancers of herbal origin: An overview
2013 Standout
Reflections of an aging free radical
2020
Optimisation and Characterisation of Lipase-Catalysed Synthesis of a Kojic Monooleate Ester in a Solvent-Free System by Response Surface Methodology
2015
Design of iron chelators with therapeutic application
2012
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Prevention of Venous Thromboembolism
2004 Standout
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Sickle-cell disease
2010 Standout
Hydroxyflavone metal complexes - molecular structure, antioxidant activity and biological effects
2017
Pathogenesis and management of iron toxicity in thalassemia
2010
What works? Interventions for maternal and child undernutrition and survival
2008 Standout
Prevention of Venous Thromboembolism
2008 Standout
G6PD: Population genetics and clinical manifestations
1996
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Indications and complications of transfusions in sickle cell disease
2012
Global epidemiology of haemoglobin disorders and derived service indicators
2008 Standout
Influence of α‐tocopherol, propolis and piperine on therapeutic potential of tiferron against beryllium induced toxic manifestations
2007
Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids
2021
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Regulating Academic–Industrial Research Relationships — Solving Problems or Stifling Progress?
2005
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Short-term daily or weekly administration of micronutrient Sprinkles™ has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster-randomised trial
2006
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia
2010
A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices
2006
Soil microbiomes and climate change
2019 Standout
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Drought and host selection influence bacterial community dynamics in the grass root microbiome
2017
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Myelodysplastic Syndromes Clinical Practice Guidelines in Oncology
2006
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences
2006
Metallodrugs in Medicinal Inorganic Chemistry
2014
Efficacy of Deep Venous Thrombosis Prophylaxis in the Medical Intensive Care Unit
2006
Pharmacological treatments for Friedreich ataxia
2016
The Effects of Cadmium Toxicity
2020 Standout
How I treat transfusional iron overload
2012
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
2007
Role of deferiprone in chelation therapy for transfusional iron overload
2003
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
2019 Standout
A review on the adsorption of heavy metals by clay minerals, with special focus on the past decade
2016 Standout
A review on heavy metal pollution, toxicity and remedial measures: Current trends and future perspectives
2019 Standout
Glucose-6-phosphate dehydrogenase deficiency
2008 Standout
Hematologically Important Mutations: Glucose-6-Phosphate Dehydrogenase
1997
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
An Improved Ant Colony Optimization Algorithm Based on Hybrid Strategies for Scheduling Problem
2019 Standout
The mono(catecholamine) derivatives as iron chelators: synthesis, solution thermodynamic stability and antioxidant properties research
2018
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets
2013
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
2005
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Works of Fernando Tricta being referenced
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease
2017
G6PD “campinas:” A deficient enzyme with a mutation at the far 3′ end of the gene
1993
The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients
2002
Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis.
2003
The Safety, Tolerability, and Efficacy of a Liquid Formulation of Deferiprone in Young Children With Transfusional Iron Overload
2010
Updates in Hemoglobinopathies
2013
Deferiprone in F riedreich ataxia: A 6‐Month randomized controlled trial
2014
Deferiprone‐induced agranulocytosis: 20 years of clinical observations
2016
Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone
2003